The many roles of an RNA editor

Nature Reviews Genetics

Volumn 2, Issue 11, 2001, Pages 869-878

  Keegan, Liam P ^a   Gallo, Angela ^a   O'Connell, Mary A ^a  

^a WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RNA;

ANIMAL; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY; REVIEW; RNA EDITING; RNA SPLICING;

ANIMAL; HUMAN; RNA; RNA EDITING; RNA SPLICING; SUPPORT, NON-U.S. GOV'T;

EID: 0035512727     PISSN: 14710056     EISSN: None     Source Type: Journal    
DOI: 10.1038/35098584     Document Type: Review

References (121)

1. Benne, R. et al. Major transcript of the frameshifted coxII gene from trypanosome mitochondria contains four nucleotides that are not encoded in the DNA. Cell 46, 819-826 (1986).
2. Powell, L. M. et al. A novel form of tissue-specific RNA processing produces apolipoprotein-48 in intestine. Cell 50, 831-840 (1987).
3. Chen, S. H. et al. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in frame stop codon. Science 238, 363-366 (1987).
4. Chan, L. Apolipoprotein B, the major protein component of triglyceride-rich and low density lipoproteins. J. Biol. Chem. 267, 25621-25624 (1992).
5. Chester, A., Scott, J., Anant, S. & Navaratnam, N. RNA editing: cytidine to uridine conversion in apolipoprotein B mRNA. Biochim. Biophys. Acta 1494, 1-13 (2000).
6. Greeve, J., Altkemper, I., Dieterich, J. H., Greten, H. & Windler, E. Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins. J. Lipid Res. 34, 1367-1383 (1993).
7. Chang, B. H.-J., Lau, P. P. & Chan, L. in Modification and Editing of RNA (eds Grosjean, H. & Benne, R.) 325-342 (ASM, Washington, DC, 1998).
8. Backus, J. W. & Smith, H. C. Specific 3′ sequences flanking a minimal apolipoprotein B (apoB) mRNA editing 'cassette' are critical for efficient editing in vitro. Biochim. Biophys. Acta 1217, 65-73 (1994).
9. Shah, R. R. et al. Sequence requirements for the editing of apolipoprotein B mRNA, J. Biol. Chem. 266, 16301-16304 (1991).
10. Driscoll, D. M., Lakhe-Reddy, S., Oteksa, L. M. & Martinez, D. Induction of RNA editing at heterologous sites by sequences in apolipoprotein B mRNA. Mol. Cell. Biol. 13, 7288-7294 (1993).
11. Hersberger, M. & Innerarity, T. L. Two efficiency elements flanking the editing site of cytidine 6666 in the apolipoprotein B mRNA support mooring-dependent editing. J. Biol. Chem. 273, 9435-9442 (1998).
12. Nakamuta, M., Tsai, A., Chan, L., Davidson, N. O. & Teng, B. B. Sequence elements required for apolipoprotein B mRNA editing enhancement activity from chicken enterocytes. Biochem. Biophys. Res. Commun. 254, 744-750 (1999).
13. Hersberger, M., Patarroyo-White, S., Arnold, K. S. & Innerarity, T. L. Phylogenetic analysis of the apolipoprotein B mRNA-editing region. Evidence for a secondary structure between the mooring sequence and the 3′ efficiency element. J. Biol. Chem. 274, 34590-34597 (1999).
14. Teng, B., Burant, C. F. & Davidson, N. O. Molecular cloning of an apolipoprotein B messenger RNA editing protein. Science 260, 1816-1819 (1993). This study describes the cloning of APOBEC1, the first editing enzyme to be cloned.
15. Mehta, A., Kinter, M. T., Sherman, N. E. & Driscoll, D. M. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA. Mol. Cell. Biol. 20, 1846-1854 (2000).
16. Lellek, H. et al. Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex. J. Biol. Chem. 275, 19848-19856 (2000).
17. Navaratnam, N. et al. The p27 catalytic subunit of the apolipoprotein B mRNA editing enzyme is a cytidine deaminase. J. Biol. Chem. 268, 20709-20712 (1993).
18. Anant, S., MacGinnitie, A. J. & Davidson, N. O. apobec-1, the catalytic subunit of the mammalian apolipoprotein B mRNA editing enzyme, is a novel RNA-binding protein. J. Biol. Chem. 270, 14762-14767 (1995).
19. Navaratnam, N. et al. Evolutionary origins of apoB mRNA editing: catalysis by a cytidine deaminase that has acquired a novel RNA-binding motif at its active site. Cell 81, 187-195 (1995).
20. Lau, P. P., Zhu, H. J., Baldini, A., Chamsangavej, C. & Chan, L. Dimeric structure of a human apolipoprotein B mRNA editing protein and cloning and chromosomal localization of its gene. Proc. Natl Acad. Sci. USA 91, 8522-8526 (1994).
21. Hadjiagapiou, C., Giannoni, F., Funahashi, T., Skarosi, S. F. & Davidson, N. O. Molecular cloning of a human small intestinal apolipoprotein B mRNA editing protein. Nucleic Acids Res. 22, 1874-1879 (1994).
22. Bhattacharya, S., Navaratnam, N., Morrison, J. R., Scott, J. & Taylor, W. R. Cytosine nucleoside/nucleotide deaminases and apolipoprotein B mRNA editing. Trends Biochem. Sci. 19, 105-106 (1994).
23. Carter, C. W. in Modification and Editing of RNA (eds Grosjean, H. & Benne, R.) 363-375 (ASM, Washington, DC, 1998).
24. Nakamuta, M. et al. Alternative mRNA splicing and differential promoter utilization determine tissue-specific expression of the apolipoprotein B mRNA-editing protein (Apobec1) gene in mice. Structure and evolution of Apobec1 and related nucleoside/nucleotide deaminases. J. Biol. Chem. 270, 13042-13056 (1995).
25. Greeve, J., Axelos, D., Welker, S., Schipper, M. & Greten, H. Distinct promoters induce APOBEC-1 expression in rat liver and intestine. Arterioscler. Thromb. Vasc. Biol. 18, 1079-1092 (1998).
26. Blanc, V. et al. Identification of GRY-RBP as an apolipoprotein B RNA-binding protein that interacts with both apobec-1 and apobec-1 complementation factor to modulate C to U editing. J. Biol. Chem. 276, 10272-10283 (2001).
27. Hirano, K. et al. Targeted disruption of the mouse apobec-1 gene abolishes apolipoprotein B mRNA editing and eliminates apolipoprotein B48. J. Biol. Chem. 271, 9887-9890 (1996).
28. Morrison, J. R. et al. Apolipoprotein B RNA editing enzyme-deficient mice are viable despite alterations in lipoprotein metabolism. Proc. Natl Acad. Sci. USA 93, 7154-7159 (1996).
29. Nakamuta, M. et al. Complete phenotypic characterization of apobec-1 knockout mice with a wild-type genetic background and a human apolipoprotein B transgenic background, and restoration of apolipoprotein B mRNA editing by somatic gene transfer of Apobec-1. J. Biol. Chem. 271, 25981-25988 (1996).
30. Yamanaka, S. et al. Apolipoprotein B mRNA-editing protein induces hepatocellular carcinoma and dysplasia in transgenic animals. Proc. Natl Acad. Sci. USA 92, 8483-8487 (1995).
31. Yamanaka, S., Poksay, K. S., Arnold, K. S. & Innerarity, T. L. A novel translational repressor mRNA is edited extensively in livers containing tumors caused by the transgene expression of the apoB mRNA-editing enzyme. Genes Dev. 11, 321-333 (1997). This study Identifies NAT1, the mRNA of which is extensively edited when APOBEC1 is overexpressed in mice and rabbits.
32. Skuse, G. R., Cappione, A. J., Sowden, M., Metheny, L. J. & Smith, H. C. The neurofibromatosis type 1 messenger RNA undergoes base-modification RNA editing. Nucleic Acids Res. 24, 478-486 (1996).
33. Liao, W. et al. APOBEC-2. a cardiac-and skeletal muscle-specific member of the cytidine deaminase supergene family. Biochem. Biophys. Res. Commun. 260, 398-404 (1999).
34. Madsen, P. et al. Psoriasis upregulated phorbolin-1 shares structural but not functional similarity to the mRNA-editing protein apobec-1. J. Invest. Dermatol. 113, 162-169 (1999).
35. Muramatsu, M. et al. Specific expression of activation-induced cytidine deaminase (AID), a novel member of the RNA-editing deaminase family in germinal center B cells. J. Biol. Chem. 274, 18470-18476 (1999). Shows the similarity between the editing enzymes APOBEC1 and AID.
36. Muto, T., Muramatsu, M., Taniwaki, M., Kinoshita, K. & Honjo, T. Isolation, tissue distribution, and chromosomal localization of the human activation-induced cytidine deaminase (AID) gene. Genomics 68, 85-88 (2000).
37. Muramatsu, M. et al. Class switch recombination and hypermutation require activation-induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102, 553-563 (2000).
38. Revy, P. et al. Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the hyper-IgM syndrome (H1GM2). Cell 102, 565-575 (2000).
39. Kinoshita, K. & Honjo, T. Unking class-switch recombination with somatic hypermutation. Nature Rev. Mol. Cell Biol. 2, 493-503 (2001).
40. Jacobs, H. & Brass, L. Towards an understanding of somatic hypermutation. Curr. Opin. Immunol. 13, 208-218 (2001).
41. Dunham, I. et al. The DNA sequence of human chromosome 22. Nature 402, 489-495 (1999).
42. Basilio, C., Wahba, A. J., Lengyel, P., Speyer, J. F. & Ochoa, S. Synthetic polynucleotides and the amino acid code. Proc. Natl Acad. Sci. USA 48, 613-616 (1962).
43. Bass, B. L. & Weintraub, H. A developmental regulated activity that unwinds RNA duplexes. Cell 48, 607-613 (1987).
44. Rebagliati, M. R. & Melton, D. A. Antisense RNA injections in fertilized frog eggs reveal an RNA duplex unwinding activity. Cell 48, 599-605 (1987).
45. Bass, B. L. et al. A standardized nomenclature for adenosine deaminases that act on RNA. RNA 3, 947-949 (1997).
46. Hough, R. F. & Bass, B. L. in RNA Editing (ed. Bass, B. L.) 77-108 (Oxford Univ. Press, 2000).
47. Wagner, R. W. et al. Double-stranded RNA unwinding and modifying activity is detected ubiquitously in primary tissues and cell lines. Mol. Cell. Biol. 10, 5586-5590 (1990).
48. Liu, Y. George, C. X., Patterson, J. B. & Samuel, C. Functionally distinct double-stranded RNA-binding domains associated with alternative splice site variants of the interferon-inducible double-stranded RNA-specific adenosine deaminase. J. Biol. Chem. 272, 4419-4428 (1997).
49. Gerber, A., O'Connell, M. A. & Keller, W. Two forms of human double-stranded RNA-specific editase 1 (hRED1) generated by the insertion of an Alu cassette. RNA 3, 453-463 (1997).
50. Lai, F., Chen, C.-X., Carter, K. C. & Nishikura, K. Editing of glutamate receptor B subunit ion channel RNAs by four alternatively spliced DRADA2 double-stranded RNA adenosine deaminases. Mol. Cell. Biol. 17, 2413-2424 (1997).
51. Melcher, T. et al. RED2, a brain specific member of the RNA-specific adenosine deaminase family. J. Biol. Chem. 271, 31795-31798 (1996).
52. Chen, C. X. et al. A third member of the RNA-specific adenosine deaminase gene family, ADAR3, contains both single-and double-stranded RNA binding domains. RNA 6, 755-767 (2000).
53. Polson, A. G., Grain, P. F., Pomerantz, S. C., McCloskey, J. A. & Bass, B. L. The mechanism of adenosine to inosine conversion by the double-stranded RNA unwinding/modifying activity: a high-performance liquid chromatography-mass spectrometry analysis. Biochemistry 30, 11507-11514 (1991).
54. Gerber, A., Grosjean, H., Melcher, T. & Keller, W. Tad1p. a yeast tRNA-specific adenosine deaminase, is related to the mammalian pre-mRNA editing enzymes ADAR1 and ADAR2. EMBO J. 17, 4780-4789 (1998). This important study shows the similarity between the enzymes involved in RNA editing and tRNA modification.
55. Gerber, A. P. & Keller, W. An adenosine deaminase that generates inosine at the wobble position of tRNAs. Science 286, 1146-1149 (1999).
56. Gerber, A. P. & Keller, W. RNA editing by base deamination: more enzymes, more targets, new mysteries. Trends Biochem. Sci. 26, 376-384 (2001).
57. St Johnston, D., Brown, N. H., Gall, J. G. & Jantsch, M. A conserved double-stranded RNA-binding domain. Proc. Natl Acad. Sci. USA 89, 10979-10983 (1992).
58. Kim, U., Wang, Y., Sanford, T., Zeng, Y. & Nishikura, K. Molecular cloning of cDNAs for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. Proc. Natl Acad. Sci. USA 91, 11457-11461 (1994).
59. O'Connell, M. A. et al. Cloning of cDNAs encoding mammalian double-stranded RNA-specific adenosine deaminase. Mol. Cell. Biol. 15, 1389-1397 (1995).
60. Lai, F., Drakas, R. & Nishikura, K. Mutagenic analysis of double-stranded RNA adenosine deaminase, a candidate enzyme for RNA editing of glutamate-gated ion channel transcripts. J. Biol. Chem. 270, 17098-17105 (1995).
61. Reinisch, K. M., Chen, L. Verdine, G. L. & Upscomb, W. N. The crystal structure of Haelll methyltransferase convalently complexed to DNA: an extrahelical cytosine and rearranged base pairing. Cell 82, 143-153 (1995).
62. Hough, R. F. & Bass, B. L. Analysis of Xenopus dsRNA adenosine deaminase cDNAs reveals similarities to DNA methyltransferases. RNA 3, 356-370 (1997).
63. Stephens, O. M., Yi-Brunozzi, H. Y. & Beal, P. A. Analysis of the RNA-editing reaction of ADAR2 with structural and fluorescent analogues of the GluR-B R/G editing site. Biochemistry 39, 12243-12251 (2000). This important study provides Insight into the mechanism of ADAR2 catalysis.
64. Higuchi, M. et al. RNA editing of AMPA receptor subunit GluR-B: a base-paired intron-exon structure determines position and efficiency. Cell 75, 1361-1370 (1993). Shows that editing of pre-mRNA by the ADAR family of enzymes requires a duplex structure and does not depend on a consensus sequence surrounding the edited position.
65. Ryter, J. M. & Schultz, S. C. Molecular basis of double-stranded RNA-protein interactions: structure of a dsRNA-binding domain complexed with dsRNA. EMBO J. 17, 7505-7513 (1998).
66. Ramos, A. et al. RNA recognition by a Stauten double-stranded RNA-binding domain. EMBO J. 19, 997-1009 (2000).
67. Yi-Brunozzi, H. Y., Stephens, O. M. & Beal, P. A. Conformational changes that occur during an RNA editing adenosine deamination reaction. J. Biol. Chem. 276, 37827-37833 (2001).
68. Wong, S. K., Sato, S. & Lazinski, D. W. Substrate recognition by ADAR1 and ADAR2. RNA 7, 846-858 (2001). Identifies the deaminase domain in the ADAR enzymes as being the main determinant of substrate specificity.
69. Patterson, J. B. & Samuel, C. E. Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase. Mol. Cell. Biol. 15, 5376-5388 (1995).
70. George, C. X. & Samuel, C. E. Human RNA-specific adenosine deaminass ADAR1 transcripts possess alternative exon 1 structures that initiate from different promoters, one constitutively active and the other interferon indicible. Proc. Natl Acad. Sci. USA 96, 4621-4626 (1999).
71. George, C. X. & Samuel, C. E. Characterization of the 5′-flanking region of the human RNA-specific adenosine deaminase ADAR1 gene and identification of an interferon-inducible ADAR1 promoter. Gene 229, 203-213 (1999).
72. Eckmann, C. R., Neunteufl, A., Pfaffstetter, L. & Jantsch, M. F. The human but not the Xenopus RNA-editing enzyme ADAR1 has an atypical nuclear localization signal and displays the characteristics of a shuttling protein. Mol. Biol. Cell 12, 1911-1924 (2001).
73. Herbert, A., Lowenhaupt, K., Spitzner, J. & Rich, A. Chicken double-stranded RNA adenosine deaminase has apparent specificity for Z-DNA. Proc. Natl Acad. Sci. USA 92, 7550-7554 (1995).
74. Herbert, A. RNA editing, introns and evolution. Trends Genet. 12, 6-9 (1996).
75. Herbert, A. et al. A Z-DNA binding domain present in the human editing enzyme, double-stranded RNA adenosine deaminase. Proc. Natl Acad. Sci. USA 94, 8421-8426 (1997).
76. Schwartz, T., Rould, M. A., Lowenhaupt, K., Herbert, A. & Rich, A. Crystal structure of the Zα domain of the human editing enzyme ADAR1 bound to left-handed Z-DNA. Science 284, 1841-1845 (1999).
77. Emeson, R. B. & Singh, M. in RNA Editing (ed. Bass, B. L.) 109-138 (Oxford Univ. Press, 2000).
78. Palladino, M. J., Keegan, L. P., O'Connell, M. A. & Reenan, R. A. dADAR, a Drosophila double-stranded RNA-specific adenosine deaminase is highly developmentally regulated and is itself a target for RNA editing. RNA 6, 1004-1018 (2000).
79. Patton, D. E., Silva, T. & Bezanilla, F. RNA editing generates a diverse array of transcripts encoding squid Kv2 K* channels with altered functional properties. Neuron 19, 711-722 (1997).
80. Seeburg, P. H. The rote of RNA editing in controlling glutamate receptor channel properties. J. Neurochem. 66, 1-5 (1996).
81. Burns, C. M. et al. Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature 387, 303-308 (1997).
82. Peixoto, A. A., Smith, L. A. & Hall, J. C. Genomic organization and evolution of alternative exons in a Drosophila calcium channel gene. Genetics 145, 1003-1013 (1997).
83. Smith, L. A. et al. A Drosophila calcium channel α1 subunit gene maps to a genetic locus associated with behavioural and visual defects. J. Neurosci. 16, 7868-7879 (1996).
84. Hanrahan, C. J., Palladino, M. J., Ganetzky, B. & Reenan, R. A. RNA editing of the Drosophila para Na(+) channel transcript. Evolutionary conservation and developmental regulation. Genetics 155, 1149-1160 (2000).
85. Semenov, E. P. & Pak, W. L. Diversification of Drosophila chloride channel gene by multiple posttranscriptional mRNA modifications. J. Neurochem. 72, 66-72 (1999).
86. Rueter, S. M., Dawson, T. R. & Emeson, R. B. Regulation of alternative splicing by RNA editing. Nature 399, 75-80 (1999).
87. Adams, M. D. et al. The genome sequence of Drosophila melanogaster. Science 287, 2185-2195 (2000).
88. Sommer, B., Köhler, M., Sprengel, R. & Seeburg, P. H. RNA editing in brain controls a determinant of ion flow in glutamate-gated channels. Cell 67, 11-19 (1991).
89. Brusa, R. et al. Early-onset epilepsy and postnatal lethality associated with editing-deficient GluR-B allele in mice. Science 270, 1677-1680 (1995). Shows the absolute requirement for editing the GluR-B transcript.
90. Lomeli, H. et al. Control of kinetic properties of AMPA receptor channels by nuclear RNA editing. Science 266, 1709-1713 (1994).
91. Melcher, T. et al. A mammalian RNA editing enzyme. Nature 379, 460-464 (1996).
92. O'Connell, M. A., Gerber, A. & Keller, W. Purification of human double-stranded RNA-specific editase1 (hRed1), involved in editing of brain glutamate receptor B pre-mRNA. J. Biol. Chem. 272, 473-478 (1997).
93. Higuchi, M. et al. Point mutation in an AMPA receptor gene rescues lethality in mice deficient in the RNA-editing enzyme ADAR2. Nature 406, 78-81 (2000). This elegant study shows that GluR-B is the crucial transcript that is edited by ADAR2.
94. Palladino, M. J., Keegan, L. P., O'Connell, M. A. & Reenan, R. A. A-to-1 pre-mRNA editing in Drosophila is primarily involved in adult nervous system function and integrity. Cell 102, 437-449 (2000). This describes the consequences on CNS function of having no Adar activity in Drosophila.
95. Wang, Q., Khillan, J., Gadue, P. & Nishikura, K. Requirement of the RNA editing deaminase ADAR1 gene for embryonic erythropoiesis. Science 290, 1765-1768 (2000).
96. Beghini, A. et al. RNA hyperediting and alternative splicing of hematopoietic cell phosphatase (PTPN6) gene in acute myeloid leukemia. Hum. Mol. Genet. 9, 2297-2304 (2000).
97. Paul, M. & Bass, B. L. Inosine exists in mRNA at tissue-specific levels and is most abundant in brain mRNA. EMBO J. 17, 1120-1127 (1998). Reports the abundance of inosine in mRNA.
98. Morse, D. P. & Bass, B. L. Detection of inosine in messenger RNA by inosine-specific cleavage. Biochemistry 36, 8429-6434 (1997). Describes the only screen that is available at present to find inosine-containing mRNA.
99. Morse, D. P. & Bass, B. L. Long RNA hairpins that contain inosine are present in Caenorhabditis elegans poly(A)+ RNA. Proc. Natl Acad. Sci. USA 96, 6048-6053 (1999).
100. Motorin, Y. & Grosjean, H. in Modification and Editing of RNA (ed. Grosjean, H. & Benne, R.) 543-549 (ASM, Washington, DC, 1998).
101. Yu, Y. T., Shu, M. D. & Steitz, J. A. Modifications of U2 snRNA are required for snRNP assembly and pre-mRNA splicing. EMBO J. 17, 5783-5795 (1998).
102. Ganot, P., Jady, B. E., Bortolin, M. L., Darzacq, X. & Kiss, T. Nucleotar factors direct the 2′-O-ribose methylation and pseudouridylation of U6 spliceosomal RNA. Mol. Cell. Biol. 19, 6906-6917 (1999).
103. Kiss, T. New EMBO member's review: small nucleolar RNA-guided post-transcriptional modification of cellular RNAs. EMBO J. 20, 3617-3622 (2001).
104. Cavaille, J. et al. Identification of brain-specific and imprinted small nucleolar RNA genes exhibiting an unusual genomic organization. Proc. Natl Acad. Sci. USA 97, 14311-14316 (2000). Indicates a possible link between snoRNP-mediated modification of mRNA and ADAR activity.
105. Filipowicz, W. Imprinted expression of small nucleolar RNAs in brain: time for RNomics. Proc. Natl Acad. Sci. USA 97, 14035-14037 (2000).
106. Yi-Brunozzi, H. Y., Easterwood, L. M., Kamilar, G. M. & Beal, P. A. Synthetic substrate analogs for the RNA-editing adenosine deaminase ADAR-2. Nucleic Acids Res. 27, 2912-2917 (1999).
107. Sodhi, M. S., Bumet, P. W., Makoff, A. J., Kerwin, R. W. & Harrison, P. J. RNA editing of the 5-HT(2C) receptor is reduced in schizophrenia. Mol. Psychiat. 6, 373-379 (2001).
108. Niswender, C. M. et al. RNA editing of the human serotonin 5-HT2C receptor. Alterations in suicide and implications for serotonergic pharmacotherapy. Neuropsychopharmacology 24, 478-491 (2001).
109. Akbarian, S., Smith, M. A. & Jones, E. G. Editing for an AMPA receptor subunit RNA in prefrontal cortex and striatum in Alzheimer's disease, Huntington's disease and schizophrenia. Brain Res. 699, 297-304 (1995).
110. Rizzetto, M. The delta agent. Hepatology 3, 729-737 (1983).
111. Polson, A. G., Bass, B. L. & Casey, J. L. RNA editing of hepatitis 6 antigenome by dsRNA-adenosine deaminase. Nature 380, 454-456 (1996).
112. Casey, J. L. & Gerin, J. L. Hepatitis D virus RNA editing: specific modification of adenosine in the antigenomic RNA. J. Mol. 69, 7593-7600 (1995).
113. Cattaneo, R. et al. Biased hypermuation and other genetic changes in defective measles viruses in human brain infections. Cell 55, 255-265 (1988).
114. Cattaneo, R., Kaelin, K., Baczko, K. & Billeter, M. A. Measles virus editing provides an additional cysteine-rich protein. Cell 56, 759-764 (1989).
115. Bass, B. L., Weintraub, H., Cattaneo, R. & Billeter, M. A. Biased hypermutation of viral RNA genomes could be due to unwinding/modification of double-stranded RNA. Cell 56, 331 (1989).
116. Bourara, K., Litvak, S. & Araya, A. Generation of G-to-A and C-to-U changes in HIV-1 transcripts by RNA editing. Science 289, 1564-1566 (2000).
117. Berkhout, B., Das, A. T. & Beerens, N. HIV-1 RNA editing, hypermutation, and error-prone reverse transcription. Science 292, 7 (2001).
118. Kumar, M. & Carmichael, G. C. Nuclear antisense RNA induces extensive adenosine modifications and nuclear retention of target transcripts. Proc. Natl Acad. Sci. USA 94, 3542-3547 (1997).
119. Zhang, Z. & Carmichael, G. G. The fate of dsRNA in the nucleus. A p54(nrb)-containing complex mediates the nuclear retention of promiscuously A-to-I edited RNAs. Cell 106, 465-475 (2001).
120. Maquat, L. E. & Carmichael, G. G. Quality control of mRNA function. Cell 104, 173-176 (2001).
121. Scadden, A. D. & Smith, C. W. Specific cleavage of hyperedited dsRNAs. EMBO J. 20, 4243-4252 (2001).